To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer

NCT06315270 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Cancer
Stage III Ovarian Cancer
Stage IV Ovarian Cancer

Sponsor

The First Hospital of Jilin University